PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
40.10%
Some net income increase while AVGO is negative at -9.78%. John Neff would see a short-term edge over the struggling competitor.
5.62%
Some D&A expansion while AVGO is negative at -0.37%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-57.14%
Negative yoy deferred tax while AVGO stands at 17.96%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
199.59%
Well above AVGO's 18.76% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
87.63%
Inventory growth well above AVGO's 26.35%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
272.97%
Growth well above AVGO's 68.61%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-841.00%
Both negative yoy, with AVGO at -33.99%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-43.00%
Negative yoy CFO while AVGO is 7.23%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
8.77%
Some CapEx rise while AVGO is negative at -44.00%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
7.91%
Less growth in investment purchases vs. AVGO's 45.71%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-27.75%
We reduce yoy sales while AVGO is 333.33%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-129.65%
We reduce yoy invests while AVGO stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
-46.67%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-0.66%
Both yoy lines negative, with AVGO at -107.07%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.